Cellular mechanisms and pathways in myocardial reperfusion injury

Ioannis Valikeserlis1, Amaryllis-Aikaterini Athanasiou2, Dimitrios Stakos3

  • 1Department of Internal Medicine, General Hospital of Chalkidiki, Polygyros.

Coronary Artery Disease
|January 20, 2021
PubMed

Insights

Ischemia-reperfusion injury involves multiple cell types and molecular pathways, impacting heart attack recovery. Understanding these cellular and molecular mechanisms is key to improving patient outcomes and reducing mortality after myocardial infarction.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Cell Biology

Background:

  • Ischemia-reperfusion injury (IRI) significantly increases mortality and hospitalization post-myocardial infarction.
  • The pathophysiology of IRI involves a complex interplay of various cell types and molecular pathways.
  • Despite advancements, precise mechanisms for all contributing cells and pathways in IRI remain under investigation.

Purpose of the Study:

  • To review the specific contributions of different cell types to IRI pathophysiology.
  • To elucidate the molecular pathways involved in IRI.
  • To provide a comprehensive understanding of IRI mechanisms for potential therapeutic targets.

Main Methods:

  • Literature review focusing on cellular and molecular mechanisms of IRI.
  • Synthesis of information on the roles of cardiomyocytes, fibroblasts, stromal cells, endothelial cells, platelets, immune cells (polymorphonuclear cells, macrophages, T lymphocytes).
  • Analysis of key molecular mediators including toll-like receptors, inflammasomes, reactive oxygen species, calcium overload, and mitochondrial dysfunction.

Main Results:

  • Endothelial dysfunction, immune activation, and inflammatory responses are critical in IRI.
  • Cardiac fibroblasts and mesenchymal stromal cells initiate and propagate inflammation via inflammasome activation.
  • Immune cells like polymorphonuclear cells and macrophages produce damaging reactive oxygen species and enzymes, while T cells modulate injury.
  • Endothelial and platelet activation contribute to microcirculation dysfunction and immune cell recruitment.

Conclusions:

  • IRI is a multifactorial process involving diverse cellular players and molecular signaling.
  • Targeting specific cellular interactions and molecular pathways (e.g., inflammasomes, oxidative stress) may offer therapeutic strategies.
  • Further research into the intricate mechanisms of IRI is essential for developing effective treatments to mitigate myocardial damage and improve recovery.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
162
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
555